{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T22:43:01Z","timestamp":1788043381748,"version":"build-2784847793"},"reference-count":227,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jaip.2018.06.002","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T21:32:56Z","timestamp":1528752776000},"page":"1462-1482.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Eosinophil-Related Disease and the Skin"],"prefix":"10.1016","volume":"6","author":[{"given":"Kristin M.","family":"Leiferman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot S.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2018.06.002_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0032-2016","article-title":"Paul Ehrlich and the early history of granulocytes","volume":"4","author":"Kay","year":"2016","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jaip.2018.06.002_bib2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/(SICI)1097-0185(199811)252:3<418::AID-AR10>3.0.CO;2-1","article-title":"Eosinophil infiltration and degranulation in normal human tissue","volume":"252","author":"Kato","year":"1998","journal-title":"Anat Rec"},{"key":"10.1016\/j.jaip.2018.06.002_bib3","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/eji.201242549","article-title":"Type 2 innate lymphoid cells-new members of the \u201ctype 2 franchise\u201d that mediate allergic airway inflammation","volume":"42","author":"Mjosberg","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nature12526","article-title":"Type 2 innate lymphoid cells control eosinophil homeostasis","volume":"502","author":"Nussbaum","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2018.06.002_bib5","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1084\/jem.20130351","article-title":"A\u00a0role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis","volume":"210","author":"Salimi","year":"2013","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2018.06.002_bib6","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/ni.2584","article-title":"Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells","volume":"14","author":"Roediger","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib7","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/icb.2013.24","article-title":"Group 2 innate lymphoid cells show up in the skin","volume":"91","author":"Spits","year":"2013","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jaip.2018.06.002_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nri3349","article-title":"Innate lymphoid cells\u2014how did we miss them?","volume":"13","author":"Walker","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib9","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20121964","article-title":"Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages","volume":"210","author":"Molofsky","year":"2013","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2018.06.002_bib10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jaci.2014.07.003","article-title":"Eosinophil-dependent skin innervation and itching following contact toxicant exposure in mice","volume":"135","author":"Lee","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib11","doi-asserted-by":"crossref","first-page":"e22029","DOI":"10.1371\/journal.pone.0022029","article-title":"Eosinophils increase neuron branching in human and murine skin and in\u00a0vitro","volume":"6","author":"Foster","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2018.06.002_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fmed.2017.00101","article-title":"Homeostatic eosinophils: characteristics and functions","volume":"4","author":"Marichal","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaip.2018.06.002_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fmed.2017.00051","article-title":"Understanding interleukin 33 and its roles in eosinophil development","volume":"4","author":"Johnston","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaip.2018.06.002_bib14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/DAD.0b013e318267caa3","article-title":"Dermatopathology of the female breast","volume":"35","author":"Peters","year":"2013","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaip.2018.06.002_bib15","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nm.1855","article-title":"Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense","volume":"14","author":"Yousefi","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2018.06.002_bib16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jaci.2010.11.002","article-title":"Eosinophil extracellular DNA traps in skin diseases","volume":"127","author":"Simon","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/ACI.0b013e328334f693","article-title":"Eosinophils as antigen-presenting cells in allergic upper airway disease","volume":"10","author":"Akuthota","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib18","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1189\/jlb.0808494","article-title":"Role of atopic status in Toll-like receptor (TLR)7- and TLR9-mediated activation of human eosinophils","volume":"85","author":"Mansson","year":"2009","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jaip.2018.06.002_bib19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1189\/jlb.0212067","article-title":"Eosinophil crystalloid granules: structure, function, and beyond","volume":"92","author":"Muniz","year":"2012","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jaip.2018.06.002_bib20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1067\/mai.2000.105712","article-title":"Mechanisms of eosinophil-associated inflammation","volume":"105","author":"Gleich","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib21","series-title":"Allergy: Principles and Practice","first-page":"305","article-title":"Biology of eosinophils","author":"Kita","year":"2003"},{"key":"10.1016\/j.jaip.2018.06.002_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0065-2776(08)01003-1","article-title":"Biology of the eosinophil","volume":"101","author":"Blanchard","year":"2009","journal-title":"Adv Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-065X.2011.01026.x","article-title":"Eosinophils: multifaceted biological properties and roles in health and disease","volume":"242","author":"Kita","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaip.2018.06.002_bib24","series-title":"Fitzpatrick\u2019s Dermatology in General Medicine","first-page":"351","article-title":"Regulation of the production and activation of eosinophils","author":"Leiferman","year":"2012"},{"key":"10.1016\/j.jaip.2018.06.002_bib25","series-title":"Eosinophils in Health and Disease","first-page":"654","author":"Lee","year":"2013"},{"key":"10.1016\/j.jaip.2018.06.002_bib26","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.12688\/f1000research.11133.1","article-title":"Recent advances in understanding eosinophil biology","volume":"6","author":"Klion","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.jaip.2018.06.002_bib27","unstructured":"Eosinophil biology and causes of eosinophilia. In: Mahoney DH Jr, Bochner BS, Eds. UpToDate. Available from: https:\/\/www.uptodate.com\/. Accessed April 7,\u00a02018."},{"key":"10.1016\/j.jaip.2018.06.002_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fmed.2017.00093","article-title":"The biology of eosinophils and their role in asthma","volume":"4","author":"McBrien","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaip.2018.06.002_bib29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fmed.2017.00103","article-title":"Bidirectional mast cell-eosinophil interactions in inflammatory disorders and cancer","volume":"4","author":"Galdiero","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaip.2018.06.002_bib30","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.jaci.2008.04.005","article-title":"A\u00a0novel IL-1 family cytokine, IL-33, potently activates human eosinophils","volume":"121","author":"Cherry","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib31","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3389\/fimmu.2014.00496","article-title":"Eosinophil secretion of granule-derived cytokines","volume":"5","author":"Spencer","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib32","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0091-6749(97)70031-9","article-title":"Dermal eosinophils in atopic dermatitis undergo cytolytic degeneration","volume":"99","author":"Cheng","year":"1997","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib33","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jaci.2003.08.028","article-title":"Interactions of eosinophil granule proteins with skin: limits of detection, persistence, and vasopermeabilization","volume":"112","author":"Davis","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib34","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0190-9622(86)70203-X","article-title":"The eosinophil and cutaneous edema","volume":"15","author":"Leiferman","year":"1986","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib35","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.4049\/jimmunol.0900055","article-title":"Eosinophil ribonucleases and their cutaneous lesion-forming activity","volume":"183","author":"Plager","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib36","first-page":"3051","article-title":"Eosinophil granule major basic protein inhibition of corneal epithelial wound healing","volume":"35","author":"Trocme","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jaip.2018.06.002_bib37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/icb.2008.72","article-title":"IL-5-overexpressing mice exhibit eosinophilia and altered wound healing through mechanisms involving prolonged inflammation","volume":"87","author":"Leitch","year":"2009","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jaip.2018.06.002_bib38","first-page":"995","article-title":"92-kd gelatinase is actively expressed by eosinophils and stored by neutrophils in squamous cell carcinoma","volume":"142","author":"Stahle-Backdahl","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaip.2018.06.002_bib39","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/1523-1747.ep12616171","article-title":"Expression of 92-kDa type IV collagenase mRNA by eosinophils associated with basal cell carcinoma","volume":"99","author":"Stahle-Backdahl","year":"1992","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib40","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1172\/JCI117196","article-title":"92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen","volume":"93","author":"Stahle-Backdahl","year":"1994","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2018.06.002_bib41","first-page":"897","article-title":"Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins","volume":"148","author":"Borrego","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaip.2018.06.002_bib42","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/all.13131","article-title":"Evidence for a role of eosinophils in blister formation in bullous pemphigoid","volume":"72","author":"de Graauw","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.06.002_bib43","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1172\/JCI115155","article-title":"Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates","volume":"87","author":"Gundel","year":"1991","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2018.06.002_bib44","first-page":"223","article-title":"Bronchial hyperreactivity and eosinophil granule proteins","volume":"43","author":"Gleich","year":"1993","journal-title":"Agents Actions Suppl"},{"key":"10.1016\/j.jaip.2018.06.002_bib45","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaci.2003.10.051","article-title":"Hypereosinophilic syndrome: case presentation and update","volume":"113","author":"Leiferman","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fmed.2017.00165","article-title":"Pathogenic effector Th2 cells in allergic eosinophilic inflammatory disease","volume":"4","author":"Mitson-Salazar","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaip.2018.06.002_bib47","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","article-title":"Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes","volume":"130","author":"Valent","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib48","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.seminhematol.2012.01.006","article-title":"Evaluation and differential diagnosis of marked, persistent eosinophilia","volume":"49","author":"Mejia","year":"2012","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jaip.2018.06.002_bib49","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.berh.2012.07.001","article-title":"IgG4-related diseases","volume":"26","author":"Guma","year":"2012","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib50","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.4049\/jimmunol.177.7.4861","article-title":"Eosinophil-derived cationic proteins activate the synthesis of remodeling factors by airway epithelial cells","volume":"177","author":"Pegorier","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib51","first-page":"521","article-title":"Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis","volume":"140","author":"Noguchi","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaip.2018.06.002_bib52","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3389\/fimmu.2017.00484","article-title":"Eosinophils in autoimmune diseases","volume":"8","author":"Diny","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13223-016-0130-4","article-title":"Primary immunodeficiencies associated with eosinophilia","volume":"12","author":"Navabi","year":"2016","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib54","series-title":"Atopic Dermatitis","first-page":"195","article-title":"Eosinophils","author":"Leiferman","year":"2009"},{"key":"10.1016\/j.jaip.2018.06.002_bib55","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamadermatol.2013.756","article-title":"Bullous pemphigoid as pruritus in the elderly: a common presentation","volume":"149","author":"Bakker","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib56","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12016-011-8252-4","article-title":"IgE, mast cells, and eosinophils in atopic dermatitis","volume":"41","author":"Liu","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib57","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/bjd.15924","article-title":"IgE autoreactivity in bullous pemphigoid: eosinophils and mast cells as major targets of pathogenic immune reactants","volume":"177","author":"Freire","year":"2017","journal-title":"Br\u00a0J Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib58","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1600-0560.1998.tb01718.x","article-title":"Histamine-containing mast cells and their relationship to NGFr-immunoreactive nerves in prurigo nodularis: a reappraisal","volume":"25","author":"Liang","year":"1998","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.jaip.2018.06.002_bib59","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archderm.1993.01680280049009","article-title":"Mast cells, neutrophils, and eosinophils in prurigo nodularis","volume":"129","author":"Perez","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib60","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000336523","article-title":"The mast cell-nerve functional unit: a key component of physiologic and pathophysiologic responses","volume":"98","author":"Forsythe","year":"2012","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.jaip.2018.06.002_bib61","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1172\/JCI116331","article-title":"Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor","volume":"91","author":"Jacoby","year":"1993","journal-title":"J\u00a0Clin Invest"},{"issue":"Pt 1","key":"10.1016\/j.jaip.2018.06.002_bib62","first-page":"L93","article-title":"Localization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function","volume":"273","author":"Costello","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jaip.2018.06.002_bib63","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jaci.2014.11.036","article-title":"Eosinophils and itch: partners in crime or strange bedfellows?","volume":"135","author":"Leiferman","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib64","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.neuroscience.2006.07.009","article-title":"Complete overlap of interleukin-31 receptor A and oncostatin M receptor beta in the adult dorsal root ganglia with distinct developmental expression patterns","volume":"142","author":"Bando","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.jaip.2018.06.002_bib65","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/exd.12587","article-title":"Repeated administration of IL-31 upregulates IL-31 receptor A (IL-31RA) in dorsal root ganglia and causes severe itch-associated scratching behaviour in mice","volume":"24","author":"Arai","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib66","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/exd.12222","article-title":"A\u00a0single dose of interleukin-31 (IL-31) causes continuous itch-associated scratching behaviour in mice","volume":"22","author":"Arai","year":"2013","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib67","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejphar.2005.04.040","article-title":"Expression of IL-31 gene transcripts in NC\/Nga mice with atopic dermatitis","volume":"516","author":"Takaoka","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaip.2018.06.002_bib68","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0625.2006.00405.x","article-title":"Involvement of IL-31 on scratching behavior in NC\/Nga mice with atopic-like dermatitis","volume":"15","author":"Takaoka","year":"2006","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib69","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-0625.2008.00766.x","article-title":"Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC\/Nga mice: a model of atopic dermatitis","volume":"18","author":"Grimstad","year":"2009","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib70","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/all.13239","article-title":"Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis","volume":"73","author":"Furue","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.06.002_bib71","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jdermsci.2017.07.019","article-title":"Elevated IL-31 serum levels in bullous pemphigoid patients correlate with eosinophil numbers and are associated with BP180-IgE","volume":"87","author":"Salz","year":"2017","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jaip.2018.06.002_bib72","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaci.2016.02.020","article-title":"The pruritus- and TH2-associated cytokine IL-31 promotes growth of sensory nerves","volume":"138","author":"Feld","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib73","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1606490","article-title":"Anti-interleukin-31 receptor A antibody for atopic dermatitis","volume":"376","author":"Ruzicka","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2018.06.002_bib74","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/09546634.2017.1290205","article-title":"Interleukin-31 pathway and its role in atopic dermatitis: a systematic review","volume":"28","author":"Saleem","year":"2017","journal-title":"J\u00a0Dermatolog Treat"},{"key":"10.1016\/j.jaip.2018.06.002_bib75","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","article-title":"IL-31: a new link between T cells and pruritus in atopic skin inflammation","volume":"117","author":"Sonkoly","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib76","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1398-9995.2009.02255.x","article-title":"Interleukin (IL)-31 induces pro-inflammatory cytokines in human monocytes and macrophages following stimulation with staphylococcal exotoxins","volume":"65","author":"Kasraie","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.06.002_bib77","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000323905","article-title":"Staphylococcal alpha-toxin induces a higher T cell proliferation and interleukin-31 in atopic dermatitis","volume":"156","author":"Niebuhr","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib78","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.4049\/jimmunol.0900712","article-title":"Antimicrobial peptides human beta-defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cells","volume":"184","author":"Niyonsaba","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib79","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/jid.2015.106","article-title":"IL-31 induces chemotaxis, calcium mobilization, release of reactive oxygen species, and CCL26 in eosinophils, which are capable to release IL-31","volume":"135","author":"Kunsleben","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib80","doi-asserted-by":"crossref","first-page":"e29815","DOI":"10.1371\/journal.pone.0029815","article-title":"Activation of eosinophils interacting with dermal fibroblasts by pruritogenic cytokine IL-31 and alarmin IL-33: implications in atopic dermatitis","volume":"7","author":"Wong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2018.06.002_bib81","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/1523-1747.ep12514346","article-title":"The structure of normal skin and the morphology of atopic eczema","volume":"67","author":"Mihm","year":"1976","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib82","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1056\/NEJM198508013130502","article-title":"Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis","volume":"313","author":"Leiferman","year":"1985","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2018.06.002_bib83","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.iac.2007.07.009","article-title":"Dermatologic manifestations of the hypereosinophilic syndromes","volume":"27","author":"Leiferman","year":"2007","journal-title":"Immunol Allergy Clin North Am"},{"issue":"Suppl","key":"10.1016\/j.jaip.2018.06.002_bib84","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1067\/mjd.2001.117022","article-title":"A\u00a0role for eosinophils in atopic dermatitis","volume":"45","author":"Leiferman","year":"2001","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib85","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.4049\/jimmunol.144.10.3961","article-title":"Eosinophil degranulation. An immunologic determinant in the pathogenesis of the Mazzotti reaction in human onchocerciasis","volume":"144","author":"Ackerman","year":"1990","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib86","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1365-2133.1996.33792.x","article-title":"Pachydermatous eosinophilic dermatitis","volume":"134","author":"Jacyk","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib87","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/1523-1747.ep12538380","article-title":"Localization of eosinophil granule major basic protein in chronic urticaria","volume":"81","author":"Peters","year":"1983","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib88","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0190-9622(89)70151-1","article-title":"Evidence for eosinophil degranulation with deposition of granule major basic protein in solar urticaria","volume":"21","author":"Leiferman","year":"1989","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"Pt 1","key":"10.1016\/j.jaip.2018.06.002_bib89","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0190-9622(87)70067-X","article-title":"Extracellular deposition of eosinophil granule major basic protein in pressure urticaria","volume":"16","author":"Peters","year":"1987","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib90","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-2133.1995.tb06916.x","article-title":"Immunohistological comparison of granulated cell proteins in induced immediate urticarial dermographism and delayed pressure urticaria lesions","volume":"133","author":"McEvoy","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib91","first-page":"579","article-title":"Extracellular deposition of eosinophil and neutrophil granule proteins in the IgE-mediated cutaneous late phase reaction","volume":"62","author":"Leiferman","year":"1990","journal-title":"Lab Invest"},{"key":"10.1016\/j.jaip.2018.06.002_bib92","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJM198406213102501","article-title":"Episodic angioedema associated with eosinophilia","volume":"310","author":"Gleich","year":"1984","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2018.06.002_bib93","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0190-9622(89)70003-7","article-title":"Episodic angioedema with eosinophilia","volume":"20","author":"Wolf","year":"1989","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib94","first-page":"62","article-title":"Hypereosinophilia and recurrent angioneurotic edema in a 2 1\/2-year-old girl","volume":"140","author":"Katzen","year":"1986","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jaip.2018.06.002_bib95","doi-asserted-by":"crossref","first-page":"503","DOI":"10.7326\/0003-4819-103-4-503","article-title":"Facial edema and eosinophilia. Evidence for eosinophil degranulation","volume":"103","author":"Songsiridej","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2018.06.002_bib96","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2222.1993.tb00896.x","article-title":"Nodules, eosinophilia, rheumatism, dermatitis and swelling (NERDS): a novel eosinophilic disorder","volume":"23","author":"Butterfield","year":"1993","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2018.06.002_bib97","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/archderm.1992.01680180049004","article-title":"Cutaneous reactions to granulocyte-monocyte colony-stimulating factor","volume":"128","author":"Mehregan","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib98","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood.V78.6.1538.1538","article-title":"Administration of interleukin-2 (IL-2) results in increased plasma concentrations of IL-5 and eosinophilia in patients with cancer","volume":"78","author":"van Haelst Pisani","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2018.06.002_bib99","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2133.1983.tb07074.x","article-title":"Immunofluorescence identification of eosinophil granule major basic protein in the flame figures of Wells' syndrome","volume":"109","author":"Peters","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib100","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/archderm.142.9.1215","article-title":"Reflections on eosinophils and flame figures: where there's smoke there's not necessarily Wells syndrome","volume":"142","author":"Leiferman","year":"2006","journal-title":"Arch Dermatol"},{"issue":"Pt 1","key":"10.1016\/j.jaip.2018.06.002_bib101","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0190-9622(98)70588-2","article-title":"Familial eosinophilic cellulitis, dysmorphic habitus, and mental retardation","volume":"38","author":"Davis","year":"1998","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib102","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archderm.1989.01670200055008","article-title":"Evidence for eosinophil degranulation in the pathogenesis of herpes gestationis","volume":"125","author":"Scheman","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib103","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1365-2230.1999.00459.x","article-title":"Polymorphic eruption of pregnancy and herpes gestationis: comparison of granulated cell proteins in tissue and serum","volume":"24","author":"Borrego","year":"1999","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib104","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0190-9622(94)70113-X","article-title":"Bullous morphea: clinical, pathologic, and immunopathologic evaluation of thirteen cases","volume":"30","author":"Daoud","year":"1994","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1067\/mjd.2002.124600","article-title":"Evidence for pathogenic involvement of eosinophils and neutrophilsin Churg-Strauss syndrome","volume":"47","author":"Drage","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib106","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1525-1470.1991.tb00295.x","article-title":"Localization of eosinophil granule major basic protein in incontinentia pigmenti","volume":"8","author":"Thyresson","year":"1991","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib107","doi-asserted-by":"crossref","first-page":"124","DOI":"10.7326\/0003-4819-113-2-124","article-title":"The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology","volume":"113","author":"Martin","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2018.06.002_bib108","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/art.1780360720","article-title":"The spectrum of eosinophilic myositis. Clinical and immunopathogenic studies of three patients, and review of the literature","volume":"36","author":"Kaufman","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaip.2018.06.002_bib109","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2249.1990.tb05445.x","article-title":"Participation of eosinophils in the toxic oil syndrome","volume":"82","author":"Ten","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib110","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nrrheum.2014.98","article-title":"Eosinophils in vasculitis: characteristics and roles in pathogenesis","volume":"10","author":"Khoury","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib111","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archderm.1994.01690090083012","article-title":"Recurrent cutaneous necrotizing eosinophilic vasculitis. A novel eosinophil-mediated syndrome","volume":"130","author":"Chen","year":"1994","journal-title":"Arch Dermatol"},{"issue":"Pt 1","key":"10.1016\/j.jaip.2018.06.002_bib112","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0190-9622(96)90318-7","article-title":"Eosinophilic vasculitis in connective tissue disease","volume":"35","author":"Chen","year":"1996","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib113","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/1529-0131(200008)43:8<1897::AID-ANR29>3.0.CO;2-I","article-title":"Churg-Strauss syndrome: localization of eosinophil major basic protein in damaged tissues","volume":"43","author":"Peen","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaip.2018.06.002_bib114","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/cup.12556","article-title":"Eosinophils in lichen sclerosus et atrophicus","volume":"42","author":"Keith","year":"2015","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.jaip.2018.06.002_bib115","series-title":"Fitzpatrick\u2019s Dermatology in General Medicine","article-title":"Eosinophils in cutaneous diseases","author":"Leiferman","year":"2012"},{"key":"10.1016\/j.jaip.2018.06.002_bib116","series-title":"Dermatology","first-page":"440","article-title":"Eosinophil-associated dermatoses","author":"Leiferman","year":"2017"},{"key":"10.1016\/j.jaip.2018.06.002_bib117","series-title":"Dermatological Signs of Systemic Disease","first-page":"69","article-title":"Eosinophil-associated diseases with dermatologic manifestations","author":"Leiferman","year":"2017"},{"issue":"Pt 2","key":"10.1016\/j.jaip.2018.06.002_bib118","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/0190-9622(91)70166-Y","article-title":"A\u00a0current perspective on the role of eosinophils in dermatologic diseases","volume":"24","author":"Leiferman","year":"1991","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib119","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.iac.2015.05.005","article-title":"Eosinophilia in dermatologic disorders","volume":"35","author":"de Graauw","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2018.06.002_bib120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12016-015-8485-8","article-title":"Eosinophilic skin diseases: a comprehensive review","volume":"50","author":"Long","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib121","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11882-006-0024-5","article-title":"Eosinophilic disorders in children","volume":"6","author":"Wagelie-Steffen","year":"2006","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2018.06.002_bib122","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2133.1999.02621.x","article-title":"Wells' syndrome (eosinophilic cellulitis): correlation between clinical activity, eosinophil levels, eosinophil cation protein and interleukin-5","volume":"140","author":"Espana","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib123","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1600-0560.2008.01045.x","article-title":"Mucocutaneous Splendore-Hoeppli phenomenon","volume":"35","author":"Hussein","year":"2008","journal-title":"J\u00a0Cutan Pathol"},{"issue":"Pt 1","key":"10.1016\/j.jaip.2018.06.002_bib124","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0190-9622(88)70016-X","article-title":"Wells' syndrome is a distinctive disease entity and not a histologic diagnosis","volume":"18","author":"Aberer","year":"1988","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/229255031202000204","article-title":"Diagnosis and management of eosinophilic cellulitis (Wells' syndrome): a case series and literature review","volume":"20","author":"Sinno","year":"2012","journal-title":"Can J Plast Surg"},{"key":"10.1016\/j.jaip.2018.06.002_bib126","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/bjd.14601","article-title":"Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database","volume":"175","author":"Bene","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib127","doi-asserted-by":"crossref","unstructured":"Kridin K, Bergman R. Association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors in patients with diabetes: estimating the risk of the new agents and characterizing the patients [published online ahead of print August 8, 2018]. JAMA Dermatol. https:\/\/doi.org\/10.1001\/jamadermatol.2018.2352.","DOI":"10.1001\/jamadermatol.2018.2352"},{"key":"10.1016\/j.jaip.2018.06.002_bib128","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fmed.2017.00179","article-title":"New insights into drug reaction with eosinophilia and systemic symptoms pathophysiology","volume":"4","author":"Musette","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaip.2018.06.002_bib129","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/ajd.12085","article-title":"Drug-reaction eosinophilia and systemic symptoms and drug-induced hypersensitivity syndrome","volume":"55","author":"Fernando","year":"2014","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib130","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/bjd.13296","article-title":"IgG4-related skin disease","volume":"171","author":"Tokura","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib131","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/intimm\/dxu074","article-title":"IgG4-related disease and its pathogenesis-cross-talk between innate and acquired immunity","volume":"26","author":"Umehara","year":"2014","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2015.09.022","article-title":"IgG4-related disease: a relatively new concept for clinicians","volume":"27","author":"Vasaitis","year":"2016","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jaip.2018.06.002_bib133","unstructured":"Moutsopoulos HM, Fragoulis GE, Stone JH. Overview of IgG4-related disease. In: Schur PH, Ed. UpToDate. Available from: https:\/\/www.uptodate.com\/. Accessed April 7, 2018."},{"key":"10.1016\/j.jaip.2018.06.002_bib134","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archderm.1966.01600280005001","article-title":"Granuloma faciale. A clinical and histopathologic review","volume":"94","author":"Pedace","year":"1966","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib135","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jaad.2005.08.021","article-title":"Granuloma faciale: a clinicopathologic study of 66 patients","volume":"53","author":"Ortonne","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib136","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/PAS.0b013e318271efd0","article-title":"Granuloma faciale: a cutaneous lesion sharing features with IgG4-associated sclerosing diseases","volume":"37","author":"Cesinaro","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaip.2018.06.002_bib137","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/ajcp\/aqw004","article-title":"Granuloma faciale and erythema elevatum diutinum in relation to immunoglobulin G4-related disease: an appraisal of 32 cases","volume":"145","author":"Kavand","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jaip.2018.06.002_bib138","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1600-0560.1993.tb00668.x","article-title":"Immunophenotypic analysis suggests that granuloma faciale is a gamma-interferon-mediated process","volume":"20","author":"Smoller","year":"1993","journal-title":"J\u00a0Cutan Pathol"},{"issue":"Pt 1","key":"10.1016\/j.jaip.2018.06.002_bib139","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0190-9622(85)70098-9","article-title":"Angiolymphoid hyperplasia with eosinophilia. A clinicopathologic study of 116 patients","volume":"12","author":"Olsen","year":"1985","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib140","first-page":"911","article-title":"Multiple papules and nodules of the scalp. Angiolymphoid hyperplasia with eosinophilia (ALHE)","volume":"146","author":"Chen","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib141","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00000372-198204000-00013","article-title":"Angiolymphoid hyperplasia with eosinophilia of the skin. Its nosological position in the spectrum of histiocytoid hemangioma","volume":"4","author":"Rosai","year":"1982","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaip.2018.06.002_bib142","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.5858\/2005-129-1168-AHWEAW","article-title":"Angiolymphoid hyperplasia with eosinophilia associated with pregnancy: a case report and review of the literature","volume":"129","author":"Zarrin-Khameh","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jaip.2018.06.002_bib143","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1746-1596-3-22","article-title":"Angiolymphoid hyperplasia with eosinophilia developing in a patient with history of peripheral T-cell lymphoma: evidence for multicentric T-cell lymphoproliferative process","volume":"3","author":"Gonzalez-Cuyar","year":"2008","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.jaip.2018.06.002_bib144","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1346-8138.2010.00818.x","article-title":"Angiolymphoid hyperplasia with eosinophilia affecting the scrotum: a rare case report with molecular evidence of T-cell clonality","volume":"37","author":"Chen","year":"2010","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib145","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1600-0560.1995.tb01414.x","article-title":"Kimura's disease and angiolymphoid hyperplasia with eosinophilia: new observations from immunohistochemical studies of lymphocyte markers, endothelial antigens, and granulocyte proteins","volume":"22","author":"Helander","year":"1995","journal-title":"J\u00a0Cutan Pathol"},{"issue":"Pt 1","key":"10.1016\/j.jaip.2018.06.002_bib146","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/000348949310200410","article-title":"Angiolymphoid hyperplasia with eosinophilia (histiocytoid hemangioma): evaluation of treatment options","volume":"102","author":"Cheney","year":"1993","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jaip.2018.06.002_bib147","first-page":"1169","article-title":"Mohs micrographic surgery for angiolymphoid hyperplasia with eosinophilia","volume":"30","author":"Miller","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaip.2018.06.002_bib148","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/jdv.12925","article-title":"Successful management of refractory angiolymphoid hyperplasia with eosinophilia with thalidomide","volume":"30","author":"Rongioletti","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2018.06.002_bib149","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000051675","article-title":"Angiolymphoid hyperplasia with eosinophilia: successful treatment with interferon alpha 2b","volume":"202","author":"Rampini","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.jaip.2018.06.002_bib150","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1468-3083.2001.03403.x","article-title":"Angiolymphoid hyperplasia with eosinophilia treated by cryosurgery","volume":"15","author":"Cooper","year":"2001","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2018.06.002_bib151","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00042728-200506000-00020","article-title":"Angiolymphoid hyperplasia successfully treated with an ultralong pulsed dye laser","volume":"31","author":"Angel","year":"2005","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaip.2018.06.002_bib152","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4103\/0378-6323.140300","article-title":"Intralesional radiofrequency ablation for nodular angiolymphoid hyperplasia on forehead: a minimally invasive approach","volume":"80","author":"Singh","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaip.2018.06.002_bib153","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-2133.2006.07178.x","article-title":"A\u00a0case of angiolymphoid hyperplasia with eosinophilia successfully treated with tacrolimus ointment","volume":"154","author":"Mashiko","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib154","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.annder.2015.02.006","article-title":"Treatment of angiolymphoid hyperplasia with eosinophilia (ALHE) using topical tacrolimus: two cases [in French]","volume":"142","author":"Nouchi","year":"2015","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaip.2018.06.002_bib155","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/00313028409067909","article-title":"Kimura's disease: a clinico-pathological study of 21 cases and its distinction from angiolymphoid hyperplasia with eosinophilia","volume":"16","author":"Kung","year":"1984","journal-title":"Pathology"},{"key":"10.1016\/j.jaip.2018.06.002_bib156","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00000478-200404000-00010","article-title":"Kimura disease: a clinicopathologic study of 21 cases","volume":"28","author":"Chen","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaip.2018.06.002_bib157","first-page":"21414","article-title":"Kimura's disease: risk factors of recurrence and prognosis","volume":"8","author":"Chen","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.jaip.2018.06.002_bib158","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12882-015-0007-7","article-title":"Diagnosis and treatment of a patient with Kimura's disease associated with nephrotic syndrome and lymphadenopathy of the epitrochlear nodes","volume":"16","author":"Zhu","year":"2015","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.jaip.2018.06.002_bib159","first-page":"211","article-title":"Membranous glomerulonephritis associated with eosinophilic lymphfolliculosis of the skin (Kimura's disease): report of a case and review of the literature","volume":"18","author":"Yamada","year":"1982","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jaip.2018.06.002_bib160","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10067-013-2462-5","article-title":"Kimura's disease or IgG4-related disease? A case-based review","volume":"34","author":"Liu","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib161","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s11239-014-1085-2","article-title":"Kimura's disease associated necrotizing eosinophilic vasculitis presenting with recurrent peripheral arterial occlusive disease: a case report and review of the literature","volume":"39","author":"Hsu","year":"2015","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jaip.2018.06.002_bib162","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jaci.2009.09.022","article-title":"Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy","volume":"124","author":"Ogbogu","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib163","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1586\/ehm.11.81","article-title":"Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field","volume":"5","author":"Valent","year":"2012","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.jaip.2018.06.002_bib164","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3389\/fmed.2017.00240","article-title":"Clinical and biological markers in hypereosinophilic syndromes","volume":"4","author":"Khoury","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaip.2018.06.002_bib165","unstructured":"Roufosse F, Klion AD, Weller PF. Hypereosinophilic syndromes: clinical manifestations, pathophysiology, and diagnosis. In: Bochner BS, Ed. UpToDate. Available from: https:\/\/www.uptodate.com\/. Accessed April 7, 2018."},{"key":"10.1016\/j.jaip.2018.06.002_bib166","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fmed.2017.00216","article-title":"(A critical appraisal of) classification of hypereosinophilic disorders","volume":"4","author":"Kahn","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaip.2018.06.002_bib167","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/ajh.24880","article-title":"World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management","volume":"92","author":"Gotlib","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaip.2018.06.002_bib168","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1001\/jama.1982.03320320054032","article-title":"Recurrent incapacitating mucosal ulcerations. A prodrome of the hypereosinophilic syndrome","volume":"247","author":"Leiferman","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2018.06.002_bib169","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2141.2009.07599.x","article-title":"The hypereosinophilic syndromes: current concepts and treatments","volume":"145","author":"Gleich","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2018.06.002_bib170","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.iac.2007.07.002","article-title":"Lymphocytic variant hypereosinophilic syndromes","volume":"27","author":"Roufosse","year":"2007","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2018.06.002_bib171","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1182\/blood-2008-08-175091","article-title":"Molecular profiling of CD3-CD4+ T cells from patients with the lymphocytic variant of hypereosinophilic syndrome reveals targeting of growth control pathways","volume":"114","author":"Ravoet","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2018.06.002_bib172","first-page":"277","article-title":"Allergic granulomatosis, allergic angiitis, and periarteritis nodosa","volume":"27","author":"Churg","year":"1951","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaip.2018.06.002_bib173","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/jid.1951.103","article-title":"Cutaneous lesions of allergic granulomatosis: a histopathologic study","volume":"17","author":"Strauss","year":"1951","journal-title":"J\u00a0Invest Dermatol"},{"issue":"Pt 1","key":"10.1016\/j.jaip.2018.06.002_bib174","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0190-9622(97)80125-9","article-title":"Cutaneous manifestations of Churg-Strauss syndrome: a clinicopathologic correlation","volume":"37","author":"Davis","year":"1997","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib175","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2133.1992.tb00114.x","article-title":"Churg-Strauss syndrome","volume":"127","author":"Schwartz","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib176","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/archderm.141.7.873","article-title":"Initial cutaneous manifestations consistent with mononeuropathy multiplex in Churg-Strauss syndrome","volume":"141","author":"Kawakami","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib177","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/all.12088","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art","volume":"68","author":"Vaglio","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.06.002_bib178","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/1529-0131(199803)41:3<445::AID-ART10>3.0.CO;2-3","article-title":"Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage","volume":"41","author":"Schmitt","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"Suppl 32","key":"10.1016\/j.jaip.2018.06.002_bib179","first-page":"S69","article-title":"Update on the pathogenesis of Churg-Strauss syndrome","volume":"21","author":"Hellmich","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib180","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2018.06.002_bib181","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fmed.2017.00128","article-title":"Tissue remodeling in chronic eosinophilic esophageal inflammation: parallels in asthma and therapeutic perspectives","volume":"4","author":"Nhu","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaip.2018.06.002_bib182","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11926-002-0006-0","article-title":"Scleroderma-like cutaneous syndromes","volume":"4","author":"Mori","year":"2002","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jaip.2018.06.002_bib183","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/art.1780380709","article-title":"Elevated levels of eosinophil major basic protein in the sera of patients with systemic sclerosis","volume":"38","author":"Cox","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaip.2018.06.002_bib184","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0161-6420(91)32200-0","article-title":"Tissue eosinophilia and eosinophil degranulation in orbital pseudotumor","volume":"98","author":"Noguchi","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaip.2018.06.002_bib185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000093847","article-title":"Eosinophilic fasciitis 30 years after\u2014what do we really know? Report of 11 patients and review of the literature","volume":"213","author":"Antic","year":"2006","journal-title":"Dermatology"},{"key":"10.1016\/j.jaip.2018.06.002_bib186","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.berh.2012.08.001","article-title":"Eosinophilic fasciitis (Shulman disease)","volume":"26","author":"Lebeaux","year":"2012","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib187","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jaad.2017.06.148","article-title":"Clinicopathologic and immunophenotypic features of eosinophilic fasciitis and morphea profunda: a comparative study of 27 cases","volume":"78","author":"Onajin","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib188","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM199003293221301","article-title":"Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan","volume":"322","author":"Hertzman","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2018.06.002_bib189","doi-asserted-by":"crossref","first-page":"140","DOI":"10.7326\/0003-4819-116-2-140","article-title":"The cause and pathogenesis of the eosinophilia-myalgia syndrome","volume":"116","author":"Varga","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2018.06.002_bib190","first-page":"259","article-title":"Eosinophilic fasciitis is clinically distinguishable from the eosinophilia-myalgia syndrome and is not associated with L-tryptophan use","volume":"18","author":"Varga","year":"1991","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib191","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/00002281-199112000-00015","article-title":"The eosinophilia-myalgia syndrome and eosinophilic fasciitis","volume":"3","author":"Jimenez","year":"1991","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib192","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00002281-199711000-00013","article-title":"Eosinophilia-myalgia syndrome, eosinophilic fasciitis, and related fibrosing disorders","volume":"9","author":"Varga","year":"1997","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib193","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/1523-1747.ep12514683","article-title":"Elevated expression of the genes for transforming growth factor-beta 1 and type VI collagen in diffuse fasciitis associated with the eosinophilia-myalgia syndrome","volume":"96","author":"Peltonen","year":"1991","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib194","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1357-2725(96)00125-2","article-title":"Increased activity of the alpha 1(I) procollagen promoter in skin fibroblasts from patients with chronic eosinophilia-myalgia syndrome","volume":"29","author":"Hitraya","year":"1997","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jaip.2018.06.002_bib195","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-4362.1992.tb03558.x","article-title":"Eosinophilia-myalgia syndrome","volume":"31","author":"Uitto","year":"1992","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib196","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1742-1241.2001.tb11066.x","article-title":"The toxic oil syndrome: 20 years on","volume":"55","author":"Diggle","year":"2001","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jaip.2018.06.002_bib197","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1021\/tx700256v","article-title":"Generation of quinoneimine intermediates in the bioactivation of 3-(N-phenylamino)alanine (PAA) by human liver microsomes: a potential link between eosinophilia-myalgia syndrome and toxic oil syndrome","volume":"20","author":"Martinez-Cabot","year":"2007","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.jaip.2018.06.002_bib198","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.imlet.2009.11.008","article-title":"AHR activation by tryptophan\u2014pathogenic hallmark of Th17-mediated inflammation in eosinophilic fasciitis, eosinophilia-myalgia-syndrome and toxic oil syndrome?","volume":"128","author":"Rieber","year":"2010","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaip.2018.06.002_bib199","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1182\/asheducation-2015.1.92","article-title":"Eosinophilia: a pragmatic approach to diagnosis and treatment","volume":"2015","author":"Klion","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jaip.2018.06.002_bib200","unstructured":"Approach to the patient with unexplained eosinophilia. In: Mahoney DH Jr, Bochner BS, Eds. UpToDate. Available from: https:\/\/www.uptodate.com\/. Accessed April 7,\u00a02018."},{"key":"10.1016\/j.jaip.2018.06.002_bib201","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/bjh.14488","article-title":"Guideline for the investigation and management of eosinophilia","volume":"176","author":"Butt","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2018.06.002_bib202","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.jaip.2018.04.030","article-title":"Consultation for elevated blood eosinophils: clinical presentations, high value diagnostic tests, and treatment options","volume":"6","author":"Khoury","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2018.06.002_bib203","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0025-6196(11)64625-9","article-title":"Myiasis due to hypoderma lineatum infection mimicking the hypereosinophilic syndrome","volume":"75","author":"Starr","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaip.2018.06.002_bib204","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJMcpc1405886","article-title":"Case records of the Massachusetts General Hospital. Case 28-2014. A 39-year-old man with a rash, headache, fever, nausea, and photophobia","volume":"371","author":"Pukkila-Worley","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2018.06.002_bib205","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.trstmh.2008.01.020","article-title":"Strongyloides hyperinfection syndrome: an emerging global infectious disease","volume":"102","author":"Marcos","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jaip.2018.06.002_bib206","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.trstmh.2007.05.021","article-title":"Strongyloides stercoralis septicaemia following steroid therapy for eosinophilia: report of three cases","volume":"101","author":"Ghosh","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jaip.2018.06.002_bib207","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/RHU.0b013e3180690933","article-title":"Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis after anti-TNF-alpha therapy","volume":"13","author":"Krishnamurthy","year":"2007","journal-title":"J\u00a0Clin Rheumatol"},{"key":"10.1016\/j.jaip.2018.06.002_bib208","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(02)08505-7","article-title":"Treatment of hypereosinophilic syndrome with imatinib mesilate","volume":"359","author":"Gleich","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2018.06.002_bib209","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1182\/blood-2014-11-551614","article-title":"How I treat hypereosinophilic syndromes","volume":"126","author":"Klion","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2018.06.002_bib210","first-page":"19","article-title":"Diagnosis and treatment of IgG4-related disease","volume":"401","author":"Kamisawa","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib211","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2010.02.026","article-title":"What targeting eosinophils has taught us about their role in diseases","volume":"126","author":"Bochner","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib212","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrd3838","article-title":"Targeting eosinophils in allergy, inflammation and beyond","volume":"12","author":"Fulkerson","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jaip.2018.06.002_bib213","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.pharmthera.2012.06.005","article-title":"Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions","volume":"135","author":"Kiwamoto","year":"2012","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jaip.2018.06.002_bib214","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa1402895","article-title":"Effects of an anti-TSLP antibody on allergen-induced asthmatic responses","volume":"370","author":"Gauvreau","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2018.06.002_bib215","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jaip.2015.01.013","article-title":"Biologic therapies targeting eosinophils: current status and future prospects","volume":"3","author":"Legrand","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2018.06.002_bib216","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1146\/annurev-pharmtox-010814-124407","article-title":"Novel targeted therapies for eosinophil-associated diseases and allergy","volume":"55","author":"Radonjic-Hoesli","year":"2015","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jaip.2018.06.002_bib217","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11899-015-0280-3","article-title":"Tyrosine kinase inhibitors and therapeutic antibodies in advanced eosinophilic disorders and systemic mastocytosis","volume":"10","author":"Gotlib","year":"2015","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.jaip.2018.06.002_bib218","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jaip.2017.08.001","article-title":"Biologic agents for the treatment of hypereosinophilic syndromes","volume":"5","author":"Kuang","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2018.06.002_bib219","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.jaci.2017.06.028","article-title":"Leveraging Siglec-8 endocytic mechanisms to kill human eosinophils and malignant mast cells","volume":"141","author":"O'Sullivan","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib220","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bcmd.2017.01.008","article-title":"The targeted eosinophil-lowering effects of dexpramipexole in clinical studies","volume":"63","author":"Dworetzky","year":"2017","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jaip.2018.06.002_bib221","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/all.12169","article-title":"The consequences of not having eosinophils","volume":"68","author":"Gleich","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.06.002_bib222","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/ni.3829","article-title":"The immunology of the allergy epidemic and the hygiene hypothesis","volume":"18","author":"Lambrecht","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaip.2018.06.002_bib223","doi-asserted-by":"crossref","first-page":"e1317420","DOI":"10.1080\/2162402X.2017.1317420","article-title":"IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils","volume":"6","author":"Lucarini","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jaip.2018.06.002_bib224","doi-asserted-by":"crossref","first-page":"e1393134","DOI":"10.1080\/2162402X.2017.1393134","article-title":"Eosinophils: the unsung heroes in cancer?","volume":"7","author":"Varricchi","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jaip.2018.06.002_bibE1","series-title":"Dermatological Signs of Systemic Disease","article-title":"Eosinophil-associated diseases with dermatologic manifestations","author":"Leiferman","year":"2017"},{"key":"10.1016\/j.jaip.2018.06.002_bibE2","series-title":"Dermatology","first-page":"440","article-title":"Eosinophil-associated dermatoses","author":"Leiferman","year":"2017"},{"key":"10.1016\/j.jaip.2018.06.002_bibE3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.iac.2004.03.007","article-title":"Dermatologic drug reactions","volume":"24","author":"McKenna","year":"2004","journal-title":"Immunol Allergy Clin North Am"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219818303908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219818303908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:17:03Z","timestamp":1761974223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219818303908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":227,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S2213219818303908"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2018.06.002","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eosinophil-Related Disease and the Skin","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2018.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}